New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 29, 2012
08:15 EDTTKMRTekmira Pharmaceuticals acquires worldwide license to novel RNAi Technology
Tekmira Pharmaceuticals announced that it has obtained a worldwide, non-exclusive license to a novel RNAi payload technology called Unlocked Nucleobase Analog, or UNA, from Marina Biotech, for the development of RNAi therapeutics. UNA technology can be used in the development of RNAi therapeutics, which treat disease by silencing specific disease causing genes. UNAs can be incorporated into RNAi drugs and have the potential to improve them by increasing their stability and reducing off-target effects.
News For TKMR From The Last 14 Days
Check below for free stories on TKMR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2014
19:51 EDTTKMRFrance discusses Ebola drug trials with Guinea authorities, Bloomberg says
Subscribe for More Information
August 28, 2014
09:52 EDTTKMRTekmira rally sharply, levels to watch
Subscribe for More Information
06:46 EDTTKMRTekmira volatility at low end of range on wide price movement
Subscribe for More Information
August 27, 2014
18:38 EDTTKMROn The Fly: After Hours Movers
Subscribe for More Information
17:49 EDTTKMRGSK, Shire rumored to be interested in Tekmira, Daily Mail says
GlaxoSmithKline (GSK) and Shire (SHPG) are rumored to be interested in a bid for Tekmira (TKMR), reports Daily Mail. Tekmira could be a value to potential suitors, capitalized at approximately GBP 400M and the company could cost over GBP 1B in a takeover, Daily Mail adds. Reference Link
August 20, 2014
14:11 EDTTKMRTekmira lipid nanoparticle targeting Marburg virus highlighted in journal
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use